Idsk -- BOSTON (EGMN) – The results of two 12-week, randomized, placebo-controlled phase III trials of linaclotide showed that the drug produced significant improvement in key end points related to chronic constipation.
Idsk -- BOSTON (EGMN) – The results of two 12-week, randomized, placebo-controlled phase III trials of linaclotide showed that the drug produced significant improvement in key end points related to chronic constipation.